LocalBusiness.com reported that RTP-based Scynexis Chemistry & Automation Inc. has secured its first round of $15 million in combined debt and equity funding. Considered a drug discovery company, Scynexis is a privately held spin-off created by a team of researchers from Aventis CropScience, which is also based in the Triangle. The company, which launched earlier this month, uses an automated system to produce and evaluate potential drug compounds. The $15 million financing round will be used for the company's operations, equipment and facilities.
CED News
« VisionAIR Secures $24 Million Series D Round | Main | B2Bmalls.com Lands $1 Million Second Round »